Canon Medical Group's VISION＆MISSION for Sustainability
We aim to be the leader in visionary healthcare solutions that inspire. We create innovative value to enrich life through the collaborative pursuit of excellence enabled by our “Made for Life” philosophy. Canon Medical Group's "Made for Life" philosophy is a long-standing commitment towards our partners, patients, and you. Built on the common understanding that relationships rely on trust, respect, and transparency, our goal is to collaborate closely with academic and industry partners to develop market-leading solutions. And with every person’s health at the heart of everything we do, we strive every day to contribute to the quality of life for all. This focus on patients motivates us to work closely with all our customers and partners to achieve common goals, finding new ways to develop intelligent products and solutions that meet global needs for enhanced clinical value and improved efficiency in healthcare solutions that are truly “Made for Life”.
We collect, integrate, process, and deliver the information needed to provide patients with efficient, high-quality healthcare. We also integrate sustainability into our strategy by applying the ESG pillars of Environment, Social, and Governance. By doing so, we ensure sustainability is part of our corporate DNA, products and services, and our contribution to society as a whole.
Top Message
At Canon Medical Group, we strive to enhance the quality of people's lives by addressing the challenges faced by healthcare professionals and patients through our products, solutions, and services, guided by our “Made for Life” philosophy. “Creating Shared Value (CSV)” is a management approach we follow, which seeks to enhance corporate value while addressing social issues.
We enhance the efficiency of medical professionals' diagnoses and readings by offering the latest technologies and improving diagnostic accuracy.
At the same time, we focus on developing "eco-design products" that aim to reduce environmental impact from the product design stage. Our efforts include saving energy during the product's use in medical institutions and establishing a recycling system for products after their life cycle ends.
We develop products and services to address the numerous challenges facing the medical field, including a shortage of healthcare professionals, an aging population, rising healthcare costs, and disparities in healthcare access across regions.
Additionally, we recognize global business trends and challenges such as the need for increased focus on circularity, measurement and data sharing, water stewardship, biodiversity, social sustainability, and sustainability education and training.
In 2024, we continued to invest in addressing Scope 3 emissions and effectively engaging consumers, while also addressing geopolitical tensions as potential barriers to sustainability investments in our supply chain.
I am proud that Canon Medical Group continues promoting circular economy initiatives to reduce environmental impact throughout the product lifecycle.
Additionally, our plan to reduce Scope 1 and 2 CO2 emissions by 42% is progressing steadily. We have also set a target to reduce Scope 3 CO2 emissions by 25% by 2030, compared to our 2022 level.
Furthermore, we value coexistence with society and will fulfill our corporate social responsibility by strengthening relationships with local communities, employees, and customers through our corporate activities.
A strong governance structure is essential for a company to achieve sustainable growth. Canon Medical Group has established a unified governance structure throughout the global group, enhancing management transparency and strengthening the relationship of trust with all stakeholders.
In addition, by strengthening internal controls and compliance, we aim to achieve sustainable growth while fulfilling our social responsibilities through early risk detection and prompt and appropriate responses. In this way, we strengthen governance and enhance credibility from a global perspective.
As we continue to face future challenges, we will promote environmental friendliness, social responsibility, and sustainable growth, and remain a trusted company in line with Canon Inc.
I am confident that our efforts will enhance the quality of life for people worldwide and contribute to the healthy development of society. I want to express my sincere gratitude to all our stakeholders for their ongoing support, and I am eager to collaborate with you throughout this endeavor.
Toshio Takiguchi, Executive Vice President, Head of Medical Group, Canon Inc.
At the same time, we focus on developing "eco-design products" that aim to reduce environmental impact from the product design stage. Our efforts include saving energy during the product's use in medical institutions and establishing a recycling system for products after their life cycle ends.
We develop products and services to address the numerous challenges facing the medical field, including a shortage of healthcare professionals, an aging population, rising healthcare costs, and disparities in healthcare access across regions.
Additionally, we recognize global business trends and challenges such as the need for increased focus on circularity, measurement and data sharing, water stewardship, biodiversity, social sustainability, and sustainability education and training.
In 2024, we continued to invest in addressing Scope 3 emissions and effectively engaging consumers, while also addressing geopolitical tensions as potential barriers to sustainability investments in our supply chain.
I am proud that Canon Medical Group continues promoting circular economy initiatives to reduce environmental impact throughout the product lifecycle.
Additionally, our plan to reduce Scope 1 and 2 CO2 emissions by 42% is progressing steadily. We have also set a target to reduce Scope 3 CO2 emissions by 25% by 2030, compared to our 2022 level.
Furthermore, we value coexistence with society and will fulfill our corporate social responsibility by strengthening relationships with local communities, employees, and customers through our corporate activities.
A strong governance structure is essential for a company to achieve sustainable growth. Canon Medical Group has established a unified governance structure throughout the global group, enhancing management transparency and strengthening the relationship of trust with all stakeholders.
In addition, by strengthening internal controls and compliance, we aim to achieve sustainable growth while fulfilling our social responsibilities through early risk detection and prompt and appropriate responses. In this way, we strengthen governance and enhance credibility from a global perspective.
As we continue to face future challenges, we will promote environmental friendliness, social responsibility, and sustainable growth, and remain a trusted company in line with Canon Inc.
I am confident that our efforts will enhance the quality of life for people worldwide and contribute to the healthy development of society. I want to express my sincere gratitude to all our stakeholders for their ongoing support, and I am eager to collaborate with you throughout this endeavor.
Toshio Takiguchi, Executive Vice President, Head of Medical Group, Canon Inc.
Scope of the Report
This report summarizes the sustainability activities carried out by Canon Medical Systems Corporation in 2024 at its headquarters in Japan and subsidiaries around the world: Japan, Singapore, China, Hong Kong, South Korea, India, Turkey, Netherlands, Belgium, Germany, Switzerland, Austria, France, Spain, Sweden, Portugal, Italy, UK, USA, Canada, Brazil, Argentina, Australia, and New Zealand.
GRI content index Latest data (Social) Latest data (Environment)
Contact
Please get in touch with our Sustainability Coordinator if you have any questions about the process and this report:
"Canon": Represents the entire group, including Canon Inc. and all of its consolidated subsidiaries.
"Canon Inc.": Represents Canon Inc. alone.
"Canon Medical Group": Represents the entire group, including Canon Medical Systems Corporation and all of its consolidated subsidiaries.
Due to medical device regulatory reasons, not all products/service displayed on this webpage are available in all countries, regions or markets. Future availability of the products/service cannot also be guaranteed. Please contact your local Canon Medical Group representative for further details.
Development and manufacturing functions of Canon Medical Systems Corporation have been transferred to CANON INC. In this website, any reference to “Canon Medical Systems Corporation” refers to “CANON INC.”
Development and manufacturing functions of Canon Medical Systems Corporation have been transferred to CANON INC. In this website, any reference to “Canon Medical Systems Corporation” refers to “CANON INC.”
